Login / Signup
Kadir Ahmad Ridwan
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Heart Failure
Angiotensin Converting Enzyme
Hypertensive Patients
Metastatic Renal Cell Carcinoma
Top Venues
Molecules (Basel, Switzerland)
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Ying Fu
,
Rengui Saxu
,
Kadir Ahmad Ridwan
,
Jiaping Yao
,
Xiaoxuan Chen
,
Xueping Xu
,
Weida Zheng
,
Peng Yu
,
Yuou Teng
Losartan Alleviates the Side Effects and Maintains the Anticancer Activity of Axitinib.
Molecules (Basel, Switzerland)
27 (9) (2022)